Table of Contents
What changed
Revenue rose 11.0% to NZ$5.2b (9% ex-FX, per management), but profit before tax fell 3.0% to NZ$383.6m. Reported NPAT jumped 31.5% to NZ$274.3m only because the prior year carried a disclosed NZ$69.2m tax abnormal; the effective tax rate normalised from 47.2% to 28.5%. PBT is the cleaner read, and on that basis operating earnings went backwards despite double-digit revenue growth.
EBITDA grew 5.7% to NZ$761.5m, well behind the revenue line, so EBITDA margin compressed by roughly 75bps to 14.5%. Operating cash flow improved to NZ$584.4m (from NZ$504.8m) and pre-lease free cash flow rose to NZ$330.7m. The final dividend was held flat at 87.0 cents per share. Net cash position narrowed, with cash down to NZ$179.4m and gross borrowings down to NZ$165.0m.
What matters
- Tax distortion is masking weaker operating earnings. NPAT growth of 31.5% sits 34.5pp above PBT growth of −3.0%, almost entirely explained by the FY24 tax abnormal. This matters because the underlying operating result is a small contraction on top of 11% revenue growth, not the expansion the headline implies.
- Operating leverage worked in reverse. Revenue grew 11% but EBITDA grew only 5.7% and PBT fell 3%, so cost growth (including depreciation, amortisation and finance costs from continued capex and lease investment) outpaced top-line expansion. For an operationally geared logistics network, this is the most important read on whether recent volume recovery is translating into earnings.
- Cash quality held up even as P&L softened. OCF/EBITDA conversion was 76.7%, in line with the three-year average of 76.6% (range 70.0%–89.0%), and pre-lease FCF of NZ$330.7m covered NPAT 1.2x. Receivable days improved to 44.7 from 47.6, so the cash result is not being flattered by working-capital release at the expense of the customer book.
Expectations
No quantified FY25 guidance, forward-work balance or formal financial target was disclosed in the supplied material, and management describes the result as "in line with our expectations and as signalled during our market update." That framing is consistent with the soft PBT outcome rather than a positive surprise, which means the read here is about durability rather than beat-or-miss.
The gap that matters for next year is between revenue momentum (11% reported, 9% constant-currency) and earnings translation (EBITDA +5.7%, PBT −3%). Without a stated margin or operating-leverage target, investors have no anchor for when, or whether, incremental revenue is expected to drop through more efficiently from FY26.
Quality of result
Underlying earnings quality is mixed. The cash side is genuinely durable: operating cash flow rose 15.8%, FCF pre-lease covered NPAT at 120.6%, capex intensity eased to 4.8% of revenue from 5.3%, and the dividend payout fell to 31.9% of NPAT (26.5% of pre-lease FCF). ROE strengthened to 13.7% from 11.3%, though that lift is itself partly a function of the tax-distorted NPAT comparison.
Reported earnings quality is weaker than it looks. The 31.5% NPAT growth is essentially a tax-rate normalisation rather than operating progress, and EBITDA margin compression on rising revenue suggests cost absorption — likely network capacity, wages and lease unwind — is running ahead of pricing or volume leverage. Net cash also narrowed (cash down NZ$34.2m against gross debt down only NZ$17.0m), so balance-sheet support did not improve in step with reported NPAT. The Group remains net cash and FX-exposed across NZ$, AU$, US$ and euro books, which means translation effects (2pp of revenue growth) are a real but non-recurring tailwind to the headline.
Unresolved
- Why did EBITDA grow only 5.7% on 11% revenue growth, and which regions or cost lines drove the margin compression?
- What is the underlying PBT trajectory expected from here, given that FY25 went backwards despite double-digit revenue growth?
- How much of the 11% reported revenue growth came from acquired, new-branch or one-off contract activity versus same-branch volume and rate?
- Will capex stay near the NZ$253.7m run-rate, and what return profile does management expect from the cumulative property and network investment?
- Why was the final dividend held flat at 87.0c despite stronger operating cash flow and lower payout ratios — is the board signalling caution on FY26 earnings?
This briefing cannot assess segment-level margin trends in detail, FY26 trading momentum, or valuation, because segment comparatives, post-balance-date trading commentary and share-price data were not in the supplied material.
Key metrics
| Metric | FY25 | FY24 | Change |
|---|---|---|---|
| Revenue | $5.2b | $4.7b | +11.0% ↑ |
| EBITDA | $761.5m | $720.6m | +5.7% ↑ |
| Net profit after tax | $274.3m | $208.7m | +31.4% ↑ |
| Net cash inflow from operating activities | $584.4m | $504.8m | +15.8% ↑ |
| Final dividend per share | 87.0c | 87.0c | flat |
| Cash and cash equivalents | $179.4m | $213.6m | -16.0% ↓ |
| Total assets | $4.1b | $3.8b | +7.7% ↑ |
Segment breakdown
| Segment | Current revenue | Prior revenue | Current result | Mix shift |
|---|---|---|---|---|
| New Zealand (NZ$) | $1.2b | — | $134.5m | n/a |
Analytical metrics
| Metric | FY25 | FY24 | Context |
|---|---|---|---|
| PBT growth | -3.0% | — | cleaner earnings measure |
| Effective tax rate | 28.5% | 47.2% | — |
| OCF / EBITDA (cash conversion) | 76.7% | 70.1% | stable |
| FCF pre-lease | $330.7m | $254.8m | +$75.9m |
| FCF / NPAT | 120.6% | 122.1% | complementary conversion metric |
| Capex % revenue | 4.8% | 5.3% | — |
| Capex | $253.7m | $250m | +$3.7m |
| Debtor days | 44.7 | 47.6 | -2.9 days |
| Trade debtors | $640.8m | $614.9m | +$25.8m |
| Net debt | −$14.4m | −$31.6m | +$17.2m |
| Net debt / EBITDA | -0.02x | -0.04x | Weakening |
| Gross borrowings | $165m | $181.9m | −$17m |
| Payout ratio vs NPAT | 31.9% | — | — |
| Payout ratio vs FCF pre-lease | 26.5% | — | covered |
| ROE (annualised) | 13.7% | 11.3% | Strengthening |
| Profit from continuing operations | — | $208.7m | — |
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.
Source-backed analysis from the filing set attached to this briefing.